从近期全球麻疹运动后覆盖率调查中汲取的经验教训。

IF 5.2 3区 医学 Q1 IMMUNOLOGY
Vaccines Pub Date : 2024-11-06 DOI:10.3390/vaccines12111257
M Carolina Danovaro-Holliday, Mitsuki Koh, Claudia Steulet, Dale A Rhoda, Mary Kay Trimner
{"title":"从近期全球麻疹运动后覆盖率调查中汲取的经验教训。","authors":"M Carolina Danovaro-Holliday, Mitsuki Koh, Claudia Steulet, Dale A Rhoda, Mary Kay Trimner","doi":"10.3390/vaccines12111257","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Measles elimination strategies include supplementary immunization activities (SIAs) to rapidly fill immunity gaps. Post-campaign coverage surveys (PCCSs) are recommended to assess SIA coverage. We characterized selected PCCSs performed following recent SIAs, highlighting specific challenges and strengths, and provide recommendations for improvement.</p><p><strong>Methods: </strong>We extracted national SIA data from the global measles/MR SIA database for the period of 2020-2023 and reviewed PCCS reports available at the World Health Organization headquarters. We extracted selected information on PCCS implementation, including information about the implementer, sampling, and main results.</p><p><strong>Results: </strong>Only 15 of 66 countries (23%) with a national-level SIA performed since 2020 had a PCCS report available. We reviewed those reports, plus six more, following three 2019 SIAs with a delayed PCCS and two PCCSs following large subnational SIAs (Kenya 2021 and Yemen 2023). All 24 PCCS reports available were from Gavi-eligible countries, with 15 from South Saharan Africa (Cameroon, the Democratic Republic of the Congo, and Ethiopia had two PCCSs). Eleven (45.8%) PCCSs were conducted within three months of the end of the SIA. All included sampling information and most had percentage of participation. Description of the interviewers' profiles varied but was limited. PCCS coverage was lower than administrative data in all but two instances. All PCCSs collected data on previous measles vaccination status that would allow exploring indicators on the SIA reaching previously measles zero-dose children. Of the 12 PCCSs reporting coverage among previously measles zero-dose children, nine reported coverage among this group of more than 50% (range: 12% and 91.6%).</p><p><strong>Conclusion: </strong>Even though a PCCS following an SIA is recommended and a requirement in Gavi-supported countries, most SIAs are not followed by a PCCS and, when performed, the timeliness of survey implementation needs improvement. Recent PCCSs were independently conducted and reports included basic survey information, but analysis and presentation of survey results vary particularly for measles zero-dose-related indicators. More guidance and technical support on how to implement PCCSs, including standardization of reports and more in-depth PCCS analyses, may help improve reporting and use of available PCCS data.</p>","PeriodicalId":23634,"journal":{"name":"Vaccines","volume":"12 11","pages":""},"PeriodicalIF":5.2000,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11598291/pdf/","citationCount":"0","resultStr":"{\"title\":\"Lessons from Recent Measles Post-Campaign Coverage Surveys Worldwide.\",\"authors\":\"M Carolina Danovaro-Holliday, Mitsuki Koh, Claudia Steulet, Dale A Rhoda, Mary Kay Trimner\",\"doi\":\"10.3390/vaccines12111257\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Measles elimination strategies include supplementary immunization activities (SIAs) to rapidly fill immunity gaps. Post-campaign coverage surveys (PCCSs) are recommended to assess SIA coverage. We characterized selected PCCSs performed following recent SIAs, highlighting specific challenges and strengths, and provide recommendations for improvement.</p><p><strong>Methods: </strong>We extracted national SIA data from the global measles/MR SIA database for the period of 2020-2023 and reviewed PCCS reports available at the World Health Organization headquarters. We extracted selected information on PCCS implementation, including information about the implementer, sampling, and main results.</p><p><strong>Results: </strong>Only 15 of 66 countries (23%) with a national-level SIA performed since 2020 had a PCCS report available. We reviewed those reports, plus six more, following three 2019 SIAs with a delayed PCCS and two PCCSs following large subnational SIAs (Kenya 2021 and Yemen 2023). All 24 PCCS reports available were from Gavi-eligible countries, with 15 from South Saharan Africa (Cameroon, the Democratic Republic of the Congo, and Ethiopia had two PCCSs). Eleven (45.8%) PCCSs were conducted within three months of the end of the SIA. All included sampling information and most had percentage of participation. Description of the interviewers' profiles varied but was limited. PCCS coverage was lower than administrative data in all but two instances. All PCCSs collected data on previous measles vaccination status that would allow exploring indicators on the SIA reaching previously measles zero-dose children. Of the 12 PCCSs reporting coverage among previously measles zero-dose children, nine reported coverage among this group of more than 50% (range: 12% and 91.6%).</p><p><strong>Conclusion: </strong>Even though a PCCS following an SIA is recommended and a requirement in Gavi-supported countries, most SIAs are not followed by a PCCS and, when performed, the timeliness of survey implementation needs improvement. Recent PCCSs were independently conducted and reports included basic survey information, but analysis and presentation of survey results vary particularly for measles zero-dose-related indicators. More guidance and technical support on how to implement PCCSs, including standardization of reports and more in-depth PCCS analyses, may help improve reporting and use of available PCCS data.</p>\",\"PeriodicalId\":23634,\"journal\":{\"name\":\"Vaccines\",\"volume\":\"12 11\",\"pages\":\"\"},\"PeriodicalIF\":5.2000,\"publicationDate\":\"2024-11-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11598291/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccines\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/vaccines12111257\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/vaccines12111257","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:消除麻疹战略包括补充免疫活动(SIA),以迅速填补免疫空白。我们建议开展活动后覆盖率调查(PCCS)来评估 SIA 的覆盖率。我们对近期 SIA 后开展的部分 PCCS 进行了描述,强调了具体的挑战和优势,并提出了改进建议:我们从全球麻疹/MR SIA 数据库中提取了 2020-2023 年期间的国家 SIA 数据,并审查了世界卫生组织总部提供的 PCCS 报告。我们提取了有关 PCCS 实施情况的部分信息,包括实施者、抽样和主要结果等信息:在自 2020 年以来进行过国家级 SIA 的 66 个国家中,只有 15 个国家(23%)有 PCCS 报告。我们审查了这些报告,以及另外 6 份报告,其中 3 份是 2019 年 SIA 后的 PCCS 报告,2 份是大型国家以下 SIA 后的 PCCS 报告(肯尼亚 2021 年和也门 2023 年)。所有 24 份 PCCS 报告均来自符合 Gavi 资格的国家,其中 15 份来自撒哈拉以南非洲(喀麦隆、刚果民主共和国和埃塞俄比亚有两份 PCCS)。有 11 份(45.8%)PCCS 是在 SIA 结束后三个月内进行的。所有 PCCS 都包含抽样信息,且大多数都有参与百分比。对访谈者的描述各不相同,但都很有限。除两次外,PCCS 的覆盖率均低于行政数据。所有 PCCS 都收集了先前麻疹疫苗接种情况的数据,从而可以探索 SIA 是否覆盖了先前麻疹零剂量儿童的指标。在 12 个报告先前麻疹零剂量儿童覆盖率的 PCCS 中,有 9 个报告该群体的覆盖率超过 50%(范围:12% 到 91.6%):尽管建议在 SIA 之后进行 PCCS,而且这也是加维支持国家的一项要求,但大多数 SIA 之后都没有进行 PCCS,即使进行了 PCCS,调查实施的及时性也有待提高。最近的 PCCS 是独立进行的,报告中包含了基本的调查信息,但调查结果的分析和介绍各不相同,特别是在麻疹零剂量相关指标方面。就如何实施 PCCS(包括报告标准化和更深入的 PCCS 分析)提供更多指导和技术支持,可能有助于改进现有 PCCS 数据的报告和使用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Lessons from Recent Measles Post-Campaign Coverage Surveys Worldwide.

Background: Measles elimination strategies include supplementary immunization activities (SIAs) to rapidly fill immunity gaps. Post-campaign coverage surveys (PCCSs) are recommended to assess SIA coverage. We characterized selected PCCSs performed following recent SIAs, highlighting specific challenges and strengths, and provide recommendations for improvement.

Methods: We extracted national SIA data from the global measles/MR SIA database for the period of 2020-2023 and reviewed PCCS reports available at the World Health Organization headquarters. We extracted selected information on PCCS implementation, including information about the implementer, sampling, and main results.

Results: Only 15 of 66 countries (23%) with a national-level SIA performed since 2020 had a PCCS report available. We reviewed those reports, plus six more, following three 2019 SIAs with a delayed PCCS and two PCCSs following large subnational SIAs (Kenya 2021 and Yemen 2023). All 24 PCCS reports available were from Gavi-eligible countries, with 15 from South Saharan Africa (Cameroon, the Democratic Republic of the Congo, and Ethiopia had two PCCSs). Eleven (45.8%) PCCSs were conducted within three months of the end of the SIA. All included sampling information and most had percentage of participation. Description of the interviewers' profiles varied but was limited. PCCS coverage was lower than administrative data in all but two instances. All PCCSs collected data on previous measles vaccination status that would allow exploring indicators on the SIA reaching previously measles zero-dose children. Of the 12 PCCSs reporting coverage among previously measles zero-dose children, nine reported coverage among this group of more than 50% (range: 12% and 91.6%).

Conclusion: Even though a PCCS following an SIA is recommended and a requirement in Gavi-supported countries, most SIAs are not followed by a PCCS and, when performed, the timeliness of survey implementation needs improvement. Recent PCCSs were independently conducted and reports included basic survey information, but analysis and presentation of survey results vary particularly for measles zero-dose-related indicators. More guidance and technical support on how to implement PCCSs, including standardization of reports and more in-depth PCCS analyses, may help improve reporting and use of available PCCS data.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Vaccines
Vaccines Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
8.90
自引率
16.70%
发文量
1853
审稿时长
18.06 days
期刊介绍: Vaccines (ISSN 2076-393X) is an international, peer-reviewed open access journal focused on laboratory and clinical vaccine research, utilization and immunization. Vaccines publishes high quality reviews, regular research papers, communications and case reports.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信